Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2017

Planlagt Fastgjort Låst Flyttet Genmab
4.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • H Offline
    H Offline
    Hen
    wrote on sidst redigeret af
    #50

    ASH abstracts offentliggøres 9:00 a.m. ET. Er det ikke nu kl 14, når vi har fået normaltid og de stadig har sommertid?

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #51

      Link Preview Image
      Webprogram Unavailable

      favicon

      (ash.confex.com)

      1 Reply Last reply
      0
      • M Offline
        M Offline
        Mcjean
        wrote on sidst redigeret af
        #52

        Vitus kan du bestemme dig? Kan kursen "snakkes" op eller kan den ikke? 😉

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #53

          good luck; i found 89 matches when searc
          hing for daratumumab lol

          1 Reply Last reply
          0
          • M Offline
            M Offline
            Mcjean
            wrote on sidst redigeret af
            #54

            89 me too wuow!

            1 Reply Last reply
            0
            • M Offline
              M Offline
              Mcjean
              wrote on sidst redigeret af
              #55

              You can take the first 8 pages and i will look from there:-)

              1 Reply Last reply
              0
              • T Offline
                T Offline
                Thomas
                wrote on sidst redigeret af
                #56

                89 matches. A pipeline within the pipeline 🙂

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #57

                  •Over 25 abstracts on Genmab partnered programs scheduled for presentation at ASH
                  •Daratumumab: 6 oral presentations; Total of over 20 abstracts accepted including ISS
                  from genmab

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Plimsoller
                    wrote on sidst redigeret af
                    #58

                    ISS?

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #59

                      investigator sponsored studies

                      1 Reply Last reply
                      0
                      • O Offline
                        O Offline
                        OHW
                        wrote on sidst redigeret af
                        #60

                        Investigator sponsored studies

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #61

                          The high potency, precision and short range of the alpha emitter, 225Ac improves the efficacy of daratumumab more than 10 fold........

                          1 Reply Last reply
                          0
                          • V Offline
                            V Offline
                            Vitus
                            wrote on sidst redigeret af
                            #62

                            Mcjean: Den kan ikke snakkes op.... der skal konkrete facts på bordet... hvordan kan du da være i tvivl -:)

                            1 Reply Last reply
                            0
                            • O Offline
                              O Offline
                              OHW
                              wrote on sidst redigeret af
                              #63

                              Investigator initiated studies (IIS) are clinical studies initiated and managed by a non-pharmaceutical company researchers, like individual investigators, institutions, collaborative study groups or cooperative groups. The researcher is responsible for the legal and regulatory responsibilities of the trial sponsor for the conduct and management of the study as defined by all applicable laws and regulations.

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Mcjean
                                wrote on sidst redigeret af
                                #64

                                Da du skriver at den blev snakket op, en kæmpe selvmodsigelse:-), men jeg forstår hvad du mener

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  Mcjean
                                  wrote on sidst redigeret af
                                  #65

                                  Abstract 739 viser at Drd er markant bedre end dr og .......This updated analysis reveals that DRd continues to demonstrate a significant PFS benefit compared with Rd alone, and pt responses continue to deepen with DRd with longer follow up. Pts who receive DRd demonstrated longer time to next therapy and responded more favorably to subsequent therapy as evidenced by prolonged PFS2, suggesting that patients continue to observe clinical benefit from prior daratumumab treatment. Importantly, the

                                  1 Reply Last reply
                                  0
                                  • M Offline
                                    M Offline
                                    Mcjean
                                    wrote on sidst redigeret af
                                    #66

                                    favorable safety profile was maintained with longer follow-up. These data support the addition of daratumumab to standard of care regimens in RRMM.

                                    1 Reply Last reply
                                    0
                                    • V Offline
                                      V Offline
                                      Vitus
                                      wrote on sidst redigeret af
                                      #67

                                      Den KUNNE snakkes op.... den tid er forbi -:)

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        Jedi
                                        wrote on sidst redigeret af
                                        #68

                                        Synes ikke jeg kan se Alcyone blandt abstract highlights fra Genmab - kommer den mon på som late-breaking abstract i stedet for?

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          gentogen
                                          wrote on sidst redigeret af
                                          #69

                                          Studies on how Dara and the ID combination induce direct programmed cell death (independent of modulating BCR signaling) are underway. Overall, our investigations provide rationale for clinical testing of Ibr combined with Dara in CLL

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger